Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Electroencephalography | 147 | 2024 | 6189 | 14.080 |
Why?
|
Seizures | 51 | 2024 | 2917 | 7.610 |
Why?
|
Coma | 19 | 2023 | 487 | 5.340 |
Why?
|
Epilepsy | 38 | 2024 | 3267 | 4.950 |
Why?
|
Brain Waves | 13 | 2023 | 401 | 3.360 |
Why?
|
Subarachnoid Hemorrhage | 15 | 2024 | 1032 | 3.270 |
Why?
|
Heart Arrest | 10 | 2023 | 1506 | 2.770 |
Why?
|
Delirium | 14 | 2024 | 1663 | 2.700 |
Why?
|
Signal Processing, Computer-Assisted | 10 | 2024 | 1489 | 2.660 |
Why?
|
Anticonvulsants | 14 | 2024 | 1879 | 2.570 |
Why?
|
Status Epilepticus | 14 | 2021 | 456 | 2.550 |
Why?
|
Sleep | 24 | 2024 | 4751 | 2.360 |
Why?
|
Sleep Stages | 13 | 2024 | 691 | 2.160 |
Why?
|
Intensive Care Units | 26 | 2023 | 3736 | 2.120 |
Why?
|
Polysomnography | 18 | 2024 | 1825 | 2.020 |
Why?
|
Sleep Apnea, Obstructive | 12 | 2023 | 1860 | 1.930 |
Why?
|
Critical Illness | 15 | 2023 | 2709 | 1.900 |
Why?
|
Models, Neurological | 8 | 2021 | 1758 | 1.690 |
Why?
|
Brain Ischemia | 13 | 2022 | 3127 | 1.620 |
Why?
|
Brain | 37 | 2024 | 26951 | 1.610 |
Why?
|
Epilepsy, Generalized | 3 | 2024 | 178 | 1.610 |
Why?
|
Propofol | 8 | 2024 | 608 | 1.600 |
Why?
|
Sleep Apnea Syndromes | 6 | 2022 | 974 | 1.570 |
Why?
|
Algorithms | 32 | 2024 | 13981 | 1.520 |
Why?
|
Critical Care | 16 | 2022 | 2699 | 1.520 |
Why?
|
Brain Injuries | 11 | 2024 | 2044 | 1.470 |
Why?
|
Monitoring, Physiologic | 15 | 2023 | 1784 | 1.430 |
Why?
|
Decision Support Techniques | 13 | 2021 | 2001 | 1.430 |
Why?
|
Brain Diseases | 5 | 2021 | 1540 | 1.410 |
Why?
|
Hepatic Encephalopathy | 3 | 2024 | 144 | 1.390 |
Why?
|
Dementia | 7 | 2024 | 2649 | 1.270 |
Why?
|
Neurotoxicity Syndromes | 2 | 2022 | 299 | 1.260 |
Why?
|
Hypoxia-Ischemia, Brain | 5 | 2020 | 352 | 1.210 |
Why?
|
Humans | 250 | 2024 | 760621 | 1.160 |
Why?
|
Benzodiazepines | 3 | 2024 | 1131 | 1.030 |
Why?
|
Epilepsy, Temporal Lobe | 4 | 2022 | 387 | 1.020 |
Why?
|
Heart Rate | 5 | 2019 | 4179 | 1.000 |
Why?
|
Respiration, Artificial | 7 | 2022 | 2622 | 0.930 |
Why?
|
Anesthetics | 3 | 2020 | 522 | 0.930 |
Why?
|
Cerebral Infarction | 4 | 2021 | 982 | 0.920 |
Why?
|
Natural Language Processing | 5 | 2024 | 1135 | 0.900 |
Why?
|
Automation | 5 | 2024 | 580 | 0.890 |
Why?
|
Hypnotics and Sedatives | 6 | 2023 | 1178 | 0.880 |
Why?
|
Glasgow Outcome Scale | 3 | 2018 | 104 | 0.860 |
Why?
|
Retrospective Studies | 56 | 2024 | 80372 | 0.840 |
Why?
|
Adult | 89 | 2024 | 219994 | 0.830 |
Why?
|
Epilepsy, Post-Traumatic | 2 | 2022 | 40 | 0.810 |
Why?
|
Middle Aged | 85 | 2024 | 220352 | 0.800 |
Why?
|
Artificial Intelligence | 6 | 2024 | 2557 | 0.790 |
Why?
|
Anesthetics, Intravenous | 4 | 2018 | 397 | 0.790 |
Why?
|
Conscious Sedation | 2 | 2016 | 529 | 0.790 |
Why?
|
Self Report | 5 | 2024 | 3711 | 0.760 |
Why?
|
Catatonia | 1 | 2024 | 178 | 0.750 |
Why?
|
Aged | 77 | 2024 | 169152 | 0.750 |
Why?
|
Electronic Health Records | 9 | 2024 | 4775 | 0.750 |
Why?
|
Extracorporeal Membrane Oxygenation | 2 | 2022 | 1459 | 0.730 |
Why?
|
Male | 113 | 2024 | 359744 | 0.730 |
Why?
|
Anesthesia, Intravenous | 2 | 2018 | 131 | 0.710 |
Why?
|
Female | 115 | 2024 | 391270 | 0.710 |
Why?
|
Alzheimer Disease | 6 | 2024 | 8547 | 0.710 |
Why?
|
Continuous Positive Airway Pressure | 3 | 2021 | 577 | 0.700 |
Why?
|
Software | 7 | 2023 | 4419 | 0.680 |
Why?
|
Confusion | 1 | 2022 | 279 | 0.670 |
Why?
|
Severity of Illness Index | 10 | 2024 | 15840 | 0.660 |
Why?
|
Neurology | 2 | 2024 | 779 | 0.640 |
Why?
|
Electrocardiography | 6 | 2020 | 6414 | 0.640 |
Why?
|
Forecasting | 3 | 2024 | 2932 | 0.620 |
Why?
|
Aging | 6 | 2024 | 8651 | 0.620 |
Why?
|
Sensitivity and Specificity | 18 | 2021 | 14660 | 0.600 |
Why?
|
Prospective Studies | 27 | 2024 | 54303 | 0.580 |
Why?
|
Evoked Potentials, Somatosensory | 1 | 2018 | 246 | 0.570 |
Why?
|
Ventilator-Induced Lung Injury | 1 | 2018 | 119 | 0.560 |
Why?
|
Computer Simulation | 8 | 2024 | 6218 | 0.560 |
Why?
|
Airway Obstruction | 1 | 2022 | 662 | 0.560 |
Why?
|
Cerebral Cortex | 6 | 2021 | 5761 | 0.560 |
Why?
|
Reproducibility of Results | 18 | 2024 | 20080 | 0.560 |
Why?
|
Deep Sedation | 1 | 2018 | 118 | 0.550 |
Why?
|
Hypothermia, Induced | 4 | 2017 | 758 | 0.540 |
Why?
|
Consciousness | 3 | 2019 | 602 | 0.530 |
Why?
|
Diagnosis | 2 | 2014 | 157 | 0.530 |
Why?
|
Models, Theoretical | 6 | 2021 | 3562 | 0.530 |
Why?
|
Sentinel Surveillance | 1 | 2018 | 293 | 0.530 |
Why?
|
Anesthetics, Inhalation | 5 | 2020 | 574 | 0.520 |
Why?
|
Ventilators, Mechanical | 1 | 2018 | 287 | 0.520 |
Why?
|
Education, Distance | 1 | 2019 | 258 | 0.520 |
Why?
|
Early Diagnosis | 3 | 2020 | 1180 | 0.510 |
Why?
|
ROC Curve | 9 | 2021 | 3568 | 0.510 |
Why?
|
Information Theory | 1 | 2014 | 49 | 0.460 |
Why?
|
Psychomotor Agitation | 1 | 2016 | 305 | 0.460 |
Why?
|
Chorea | 1 | 2014 | 79 | 0.450 |
Why?
|
Probability | 5 | 2018 | 2475 | 0.450 |
Why?
|
Life Expectancy | 2 | 2021 | 1248 | 0.450 |
Why?
|
Periodicity | 4 | 2021 | 348 | 0.440 |
Why?
|
Prognosis | 16 | 2022 | 29658 | 0.440 |
Why?
|
Nonlinear Dynamics | 1 | 2016 | 494 | 0.440 |
Why?
|
Cerebrospinal Fluid Shunts | 1 | 2014 | 195 | 0.430 |
Why?
|
Inpatients | 3 | 2023 | 2581 | 0.430 |
Why?
|
Patient Discharge | 3 | 2023 | 3476 | 0.420 |
Why?
|
Vagus Nerve Stimulation | 1 | 2016 | 224 | 0.420 |
Why?
|
Immunotherapy, Adoptive | 2 | 2022 | 1454 | 0.410 |
Why?
|
Respiration | 2 | 2020 | 1654 | 0.400 |
Why?
|
Basal Ganglia Hemorrhage | 1 | 2011 | 7 | 0.400 |
Why?
|
Epidemiologic Methods | 1 | 2017 | 1343 | 0.400 |
Why?
|
Cost-Benefit Analysis | 5 | 2021 | 5508 | 0.380 |
Why?
|
Circadian Rhythm | 1 | 2023 | 2571 | 0.380 |
Why?
|
Cost of Illness | 1 | 2021 | 1940 | 0.380 |
Why?
|
Efficiency | 1 | 2014 | 477 | 0.370 |
Why?
|
Brain Infarction | 1 | 2013 | 292 | 0.370 |
Why?
|
Hematologic Neoplasms | 1 | 2022 | 1895 | 0.360 |
Why?
|
Polycythemia | 1 | 2011 | 125 | 0.360 |
Why?
|
Preventive Medicine | 1 | 2012 | 250 | 0.360 |
Why?
|
Secondary Prevention | 3 | 2021 | 1548 | 0.360 |
Why?
|
Dexmedetomidine | 3 | 2023 | 316 | 0.360 |
Why?
|
Movement Disorders | 1 | 2014 | 459 | 0.350 |
Why?
|
Aged, 80 and over | 27 | 2021 | 58995 | 0.350 |
Why?
|
Intracranial Aneurysm | 2 | 2018 | 1276 | 0.340 |
Why?
|
Databases, Factual | 6 | 2020 | 8035 | 0.340 |
Why?
|
Intensive Care Units, Neonatal | 1 | 2017 | 833 | 0.340 |
Why?
|
Neurophysiology | 2 | 2023 | 144 | 0.340 |
Why?
|
Research Design | 5 | 2024 | 6180 | 0.340 |
Why?
|
Markov Chains | 6 | 2018 | 968 | 0.340 |
Why?
|
Treatment Outcome | 16 | 2024 | 65017 | 0.340 |
Why?
|
Young Adult | 26 | 2024 | 58741 | 0.330 |
Why?
|
Cross Infection | 2 | 2018 | 1434 | 0.330 |
Why?
|
Cohort Studies | 18 | 2024 | 41335 | 0.330 |
Why?
|
Metabolome | 1 | 2016 | 982 | 0.320 |
Why?
|
Predictive Value of Tests | 12 | 2021 | 15289 | 0.320 |
Why?
|
Decision Trees | 4 | 2020 | 506 | 0.310 |
Why?
|
Brain Mapping | 5 | 2020 | 6568 | 0.310 |
Why?
|
Accidents, Traffic | 1 | 2014 | 814 | 0.310 |
Why?
|
Monitoring, Intraoperative | 1 | 2015 | 942 | 0.310 |
Why?
|
Anesthesia | 3 | 2017 | 1584 | 0.300 |
Why?
|
Physicians | 2 | 2020 | 4591 | 0.300 |
Why?
|
Time Factors | 16 | 2020 | 40165 | 0.300 |
Why?
|
Stroke | 8 | 2024 | 9962 | 0.300 |
Why?
|
Risk Assessment | 9 | 2021 | 24123 | 0.290 |
Why?
|
Observer Variation | 5 | 2020 | 2601 | 0.290 |
Why?
|
Memory Disorders | 1 | 2014 | 1197 | 0.280 |
Why?
|
Epilepsies, Partial | 3 | 2021 | 430 | 0.280 |
Why?
|
Internship and Residency | 2 | 2024 | 5870 | 0.270 |
Why?
|
Academic Medical Centers | 4 | 2022 | 2754 | 0.270 |
Why?
|
Out-of-Hospital Cardiac Arrest | 2 | 2022 | 347 | 0.270 |
Why?
|
Bayes Theorem | 5 | 2018 | 2326 | 0.270 |
Why?
|
Quality-Adjusted Life Years | 4 | 2021 | 1724 | 0.270 |
Why?
|
Nerve Net | 5 | 2020 | 2261 | 0.270 |
Why?
|
Cerebral Hemorrhage | 3 | 2021 | 2660 | 0.260 |
Why?
|
Equipment Design | 1 | 2014 | 3520 | 0.260 |
Why?
|
Cerebral Angiography | 1 | 2011 | 1274 | 0.260 |
Why?
|
False Positive Reactions | 3 | 2018 | 956 | 0.260 |
Why?
|
Methyl Ethers | 3 | 2019 | 196 | 0.260 |
Why?
|
Cardiac Surgical Procedures | 4 | 2023 | 3620 | 0.250 |
Why?
|
Age Factors | 3 | 2020 | 18416 | 0.240 |
Why?
|
Military Personnel | 1 | 2014 | 1244 | 0.240 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2022 | 8950 | 0.240 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2014 | 1079 | 0.240 |
Why?
|
Data Interpretation, Statistical | 4 | 2014 | 2696 | 0.240 |
Why?
|
Cerebrovascular Disorders | 1 | 2011 | 1501 | 0.230 |
Why?
|
Thalamus | 2 | 2021 | 1041 | 0.230 |
Why?
|
Neurosurgical Procedures | 1 | 2015 | 2056 | 0.230 |
Why?
|
Anesthesia, General | 4 | 2019 | 1166 | 0.230 |
Why?
|
Cross-Sectional Studies | 8 | 2023 | 25942 | 0.230 |
Why?
|
Action Potentials | 2 | 2021 | 1816 | 0.220 |
Why?
|
Oxygen | 3 | 2021 | 4193 | 0.220 |
Why?
|
Pilot Projects | 4 | 2024 | 8555 | 0.210 |
Why?
|
Time | 2 | 2022 | 545 | 0.210 |
Why?
|
Hospitalization | 7 | 2023 | 10790 | 0.210 |
Why?
|
Computational Biology | 1 | 2014 | 3505 | 0.200 |
Why?
|
Disease Management | 1 | 2013 | 2514 | 0.200 |
Why?
|
Cortical Spreading Depression | 2 | 2016 | 288 | 0.200 |
Why?
|
Adolescent | 19 | 2023 | 87810 | 0.190 |
Why?
|
Mass Screening | 2 | 2014 | 5423 | 0.190 |
Why?
|
Diagnostic Techniques and Procedures | 2 | 2014 | 220 | 0.190 |
Why?
|
Hospitals, Urban | 1 | 2023 | 499 | 0.190 |
Why?
|
Quality of Life | 4 | 2018 | 13308 | 0.190 |
Why?
|
Noise | 1 | 2023 | 280 | 0.190 |
Why?
|
Sturge-Weber Syndrome | 1 | 2022 | 85 | 0.190 |
Why?
|
Hospital Mortality | 4 | 2023 | 5425 | 0.180 |
Why?
|
Problem Solving | 1 | 2023 | 440 | 0.180 |
Why?
|
Implantable Neurostimulators | 1 | 2021 | 72 | 0.180 |
Why?
|
Respiratory Rate | 1 | 2021 | 175 | 0.180 |
Why?
|
Artifacts | 3 | 2019 | 1898 | 0.170 |
Why?
|
Logistic Models | 3 | 2022 | 13314 | 0.170 |
Why?
|
Epilepsy, Rolandic | 1 | 2020 | 54 | 0.170 |
Why?
|
Cognition | 5 | 2024 | 6957 | 0.170 |
Why?
|
Erythrocyte Indices | 1 | 2020 | 145 | 0.170 |
Why?
|
Myoclonus | 1 | 2020 | 107 | 0.170 |
Why?
|
Technology | 1 | 2022 | 291 | 0.170 |
Why?
|
Hospitals | 6 | 2023 | 3928 | 0.170 |
Why?
|
Vasospasm, Intracranial | 1 | 2021 | 215 | 0.160 |
Why?
|
Length of Stay | 3 | 2022 | 6479 | 0.160 |
Why?
|
Cluster Analysis | 3 | 2020 | 2698 | 0.160 |
Why?
|
Massachusetts | 3 | 2024 | 8803 | 0.160 |
Why?
|
Infection Control Practitioners | 1 | 2018 | 12 | 0.160 |
Why?
|
HIV Infections | 2 | 2023 | 17165 | 0.160 |
Why?
|
Uncertainty | 2 | 2014 | 754 | 0.150 |
Why?
|
Electrodes | 1 | 2020 | 614 | 0.150 |
Why?
|
Phenytoin | 1 | 2018 | 188 | 0.150 |
Why?
|
Cerebrovascular Circulation | 3 | 2016 | 2733 | 0.150 |
Why?
|
Brain Edema | 1 | 2022 | 603 | 0.140 |
Why?
|
Adrenergic alpha-2 Receptor Agonists | 1 | 2018 | 91 | 0.140 |
Why?
|
Delta Rhythm | 1 | 2017 | 81 | 0.140 |
Why?
|
Aspirin | 3 | 2014 | 3364 | 0.140 |
Why?
|
Potassium | 1 | 2021 | 1313 | 0.140 |
Why?
|
Clinical Competence | 2 | 2024 | 4783 | 0.140 |
Why?
|
Microvessels | 1 | 2021 | 572 | 0.140 |
Why?
|
Magnetic Resonance Imaging | 10 | 2024 | 36290 | 0.140 |
Why?
|
Physical Endurance | 1 | 2018 | 363 | 0.130 |
Why?
|
False Negative Reactions | 2 | 2014 | 573 | 0.130 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2011 | 3334 | 0.130 |
Why?
|
United States | 8 | 2023 | 72461 | 0.130 |
Why?
|
Intensive Care, Neonatal | 1 | 2017 | 197 | 0.120 |
Why?
|
Clonazepam | 1 | 2015 | 133 | 0.120 |
Why?
|
Risk Factors | 14 | 2024 | 74359 | 0.120 |
Why?
|
Wakefulness | 2 | 2020 | 1255 | 0.120 |
Why?
|
Electric Stimulation Therapy | 1 | 2021 | 613 | 0.120 |
Why?
|
Longevity | 1 | 2023 | 1050 | 0.120 |
Why?
|
Electrodes, Implanted | 1 | 2019 | 833 | 0.120 |
Why?
|
Thoracic Surgery | 1 | 2021 | 725 | 0.120 |
Why?
|
Prevalence | 2 | 2022 | 15687 | 0.120 |
Why?
|
North America | 1 | 2018 | 1284 | 0.120 |
Why?
|
Periventricular Nodular Heterotopia | 1 | 2015 | 53 | 0.120 |
Why?
|
Sclerosis | 1 | 2015 | 210 | 0.120 |
Why?
|
Analgesics | 1 | 2021 | 1065 | 0.120 |
Why?
|
Smoking | 1 | 2011 | 9073 | 0.120 |
Why?
|
Risk | 4 | 2017 | 9631 | 0.120 |
Why?
|
Lorazepam | 1 | 2015 | 154 | 0.120 |
Why?
|
Self Concept | 1 | 2020 | 1039 | 0.120 |
Why?
|
Nasal Obstruction | 1 | 2016 | 159 | 0.120 |
Why?
|
Withholding Treatment | 1 | 2018 | 613 | 0.120 |
Why?
|
Single-Blind Method | 2 | 2018 | 1578 | 0.120 |
Why?
|
Autonomic Nervous System | 1 | 2019 | 697 | 0.110 |
Why?
|
Neurodegenerative Diseases | 1 | 2023 | 1084 | 0.110 |
Why?
|
Databases as Topic | 1 | 2016 | 474 | 0.110 |
Why?
|
Cardiopulmonary Resuscitation | 1 | 2022 | 1004 | 0.110 |
Why?
|
Diagnosis, Computer-Assisted | 2 | 2018 | 707 | 0.110 |
Why?
|
Homeostasis | 2 | 2022 | 3306 | 0.110 |
Why?
|
Drug Therapy, Computer-Assisted | 1 | 2015 | 198 | 0.110 |
Why?
|
Midazolam | 1 | 2015 | 267 | 0.110 |
Why?
|
Motor Cortex | 1 | 2021 | 995 | 0.110 |
Why?
|
Biological Clocks | 1 | 2015 | 316 | 0.110 |
Why?
|
Transcranial Magnetic Stimulation | 3 | 2021 | 1469 | 0.110 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2023 | 2895 | 0.100 |
Why?
|
Health Services Needs and Demand | 1 | 2020 | 1399 | 0.100 |
Why?
|
Outpatients | 1 | 2021 | 1607 | 0.100 |
Why?
|
Diagnostic Tests, Routine | 1 | 2018 | 786 | 0.100 |
Why?
|
Spectrum Analysis | 1 | 2014 | 453 | 0.100 |
Why?
|
Patient Admission | 2 | 2020 | 1386 | 0.100 |
Why?
|
International Cooperation | 1 | 2018 | 1433 | 0.100 |
Why?
|
Pharmaceutical Preparations | 1 | 2020 | 1091 | 0.100 |
Why?
|
Temporal Lobe | 1 | 2019 | 1688 | 0.100 |
Why?
|
Consciousness Disorders | 1 | 2016 | 440 | 0.100 |
Why?
|
Point-of-Care Systems | 1 | 2020 | 1204 | 0.100 |
Why?
|
Comorbidity | 3 | 2022 | 10551 | 0.100 |
Why?
|
Demography | 1 | 2016 | 1650 | 0.100 |
Why?
|
Multiple Sclerosis, Relapsing-Remitting | 1 | 2017 | 556 | 0.090 |
Why?
|
Fluorodeoxyglucose F18 | 2 | 2019 | 2007 | 0.090 |
Why?
|
Radionuclide Imaging | 1 | 2015 | 1975 | 0.090 |
Why?
|
Clinical Trials as Topic | 2 | 2018 | 8056 | 0.090 |
Why?
|
Erythrocytes | 1 | 2020 | 2415 | 0.090 |
Why?
|
Monitoring, Ambulatory | 1 | 2014 | 353 | 0.090 |
Why?
|
Nervous System Diseases | 1 | 2021 | 1647 | 0.090 |
Why?
|
Electrophysiological Phenomena | 1 | 2013 | 309 | 0.090 |
Why?
|
Microcirculation | 1 | 2015 | 1278 | 0.090 |
Why?
|
Atrophy | 1 | 2015 | 1627 | 0.090 |
Why?
|
Radiopharmaceuticals | 2 | 2019 | 2634 | 0.090 |
Why?
|
Creutzfeldt-Jakob Syndrome | 1 | 2010 | 91 | 0.090 |
Why?
|
Hematocrit | 1 | 2011 | 629 | 0.090 |
Why?
|
Platelet Aggregation Inhibitors | 2 | 2014 | 3201 | 0.090 |
Why?
|
Antipsychotic Agents | 1 | 2023 | 3061 | 0.090 |
Why?
|
Magnetic Resonance Angiography | 1 | 2016 | 1431 | 0.080 |
Why?
|
Positron-Emission Tomography | 3 | 2019 | 6465 | 0.080 |
Why?
|
Alpha Rhythm | 2 | 2024 | 109 | 0.080 |
Why?
|
Sleep, REM | 3 | 2024 | 593 | 0.080 |
Why?
|
Myocardial Infarction | 1 | 2011 | 11891 | 0.080 |
Why?
|
Calcium | 1 | 2022 | 5725 | 0.080 |
Why?
|
Likelihood Functions | 1 | 2012 | 987 | 0.080 |
Why?
|
Diagnosis, Differential | 3 | 2021 | 12965 | 0.080 |
Why?
|
Autopsy | 1 | 2013 | 1007 | 0.080 |
Why?
|
Neural Pathways | 3 | 2021 | 3040 | 0.080 |
Why?
|
Practice Guidelines as Topic | 3 | 2016 | 7475 | 0.080 |
Why?
|
Scalp | 2 | 2022 | 389 | 0.080 |
Why?
|
Case-Control Studies | 3 | 2022 | 22053 | 0.080 |
Why?
|
Posture | 1 | 2012 | 953 | 0.080 |
Why?
|
Boston | 2 | 2020 | 9280 | 0.080 |
Why?
|
Glasgow Coma Scale | 2 | 2022 | 579 | 0.080 |
Why?
|
Least-Squares Analysis | 2 | 2013 | 369 | 0.070 |
Why?
|
Disorders of Excessive Somnolence | 1 | 2011 | 277 | 0.070 |
Why?
|
Hydrocephalus | 1 | 2014 | 763 | 0.070 |
Why?
|
Databases, Genetic | 1 | 2014 | 1738 | 0.070 |
Why?
|
Immunologic Factors | 1 | 2017 | 1588 | 0.070 |
Why?
|
Hippocampus | 2 | 2022 | 3738 | 0.070 |
Why?
|
Follow-Up Studies | 2 | 2021 | 39261 | 0.070 |
Why?
|
Quality Improvement | 1 | 2022 | 3836 | 0.070 |
Why?
|
Terminology as Topic | 1 | 2014 | 1535 | 0.070 |
Why?
|
Glucose | 1 | 2019 | 4351 | 0.070 |
Why?
|
Unconsciousness | 2 | 2022 | 251 | 0.070 |
Why?
|
Diffusion Magnetic Resonance Imaging | 2 | 2016 | 2782 | 0.070 |
Why?
|
Adenosine Triphosphate | 1 | 2013 | 1993 | 0.070 |
Why?
|
Consensus | 1 | 2016 | 3113 | 0.070 |
Why?
|
Models, Statistical | 2 | 2018 | 5075 | 0.070 |
Why?
|
Recurrence | 1 | 2018 | 8482 | 0.070 |
Why?
|
Acute Disease | 2 | 2019 | 7269 | 0.060 |
Why?
|
Quality Assurance, Health Care | 1 | 2016 | 2176 | 0.060 |
Why?
|
Sepsis | 1 | 2020 | 2592 | 0.060 |
Why?
|
Chronic Disease | 1 | 2020 | 9287 | 0.060 |
Why?
|
Syndrome | 1 | 2011 | 3280 | 0.060 |
Why?
|
Primary Prevention | 1 | 2012 | 1207 | 0.060 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2022 | 9276 | 0.060 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2014 | 2282 | 0.060 |
Why?
|
Cardiopulmonary Bypass | 2 | 2020 | 1096 | 0.060 |
Why?
|
Incidence | 1 | 2022 | 21392 | 0.060 |
Why?
|
Child | 8 | 2022 | 79806 | 0.060 |
Why?
|
Postoperative Complications | 3 | 2023 | 15697 | 0.060 |
Why?
|
Catheterization, Central Venous | 1 | 2008 | 526 | 0.050 |
Why?
|
Residence Characteristics | 1 | 2013 | 2062 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3085 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3205 | 0.050 |
Why?
|
Otolithic Membrane | 1 | 2002 | 38 | 0.050 |
Why?
|
Sodium-Calcium Exchanger | 1 | 2022 | 89 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2015 | 10827 | 0.050 |
Why?
|
Delivery of Health Care | 1 | 2020 | 5325 | 0.050 |
Why?
|
Epilepsia Partialis Continua | 1 | 2021 | 18 | 0.050 |
Why?
|
Psychometrics | 1 | 2011 | 3051 | 0.050 |
Why?
|
Bacteremia | 1 | 2008 | 980 | 0.050 |
Why?
|
Acceleration | 1 | 2002 | 189 | 0.050 |
Why?
|
Competency-Based Education | 1 | 2022 | 218 | 0.050 |
Why?
|
Semicircular Canals | 1 | 2002 | 203 | 0.050 |
Why?
|
Infant, Newborn | 2 | 2019 | 26181 | 0.040 |
Why?
|
Vestibule, Labyrinth | 1 | 2002 | 232 | 0.040 |
Why?
|
Foramen Ovale | 1 | 2019 | 17 | 0.040 |
Why?
|
Ultrasonography, Doppler, Transcranial | 1 | 2021 | 281 | 0.040 |
Why?
|
Diabetes Mellitus | 1 | 2018 | 5889 | 0.040 |
Why?
|
Communication | 1 | 2014 | 3849 | 0.040 |
Why?
|
Data Mining | 1 | 2024 | 553 | 0.040 |
Why?
|
Severe Acute Respiratory Syndrome | 1 | 2020 | 137 | 0.040 |
Why?
|
Recovery of Function | 2 | 2020 | 2985 | 0.040 |
Why?
|
Research Report | 1 | 2022 | 370 | 0.040 |
Why?
|
Education, Medical | 1 | 2011 | 1727 | 0.040 |
Why?
|
Calcium Channels | 1 | 2022 | 619 | 0.040 |
Why?
|
Child, Preschool | 5 | 2021 | 42063 | 0.040 |
Why?
|
Classification | 1 | 2018 | 127 | 0.040 |
Why?
|
Hypertension | 1 | 2018 | 8594 | 0.040 |
Why?
|
Hospitals, Private | 1 | 2018 | 63 | 0.040 |
Why?
|
Posterior Leukoencephalopathy Syndrome | 1 | 2019 | 50 | 0.040 |
Why?
|
Solubility | 1 | 2020 | 1088 | 0.040 |
Why?
|
Coronavirus | 1 | 2020 | 149 | 0.040 |
Why?
|
Insurance Claim Reporting | 1 | 2018 | 165 | 0.040 |
Why?
|
Population Surveillance | 1 | 2008 | 2608 | 0.040 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2024 | 10344 | 0.040 |
Why?
|
Academies and Institutes | 1 | 2020 | 319 | 0.040 |
Why?
|
Frail Elderly | 1 | 2023 | 752 | 0.040 |
Why?
|
Evaluation Studies as Topic | 1 | 2019 | 1628 | 0.040 |
Why?
|
Video Recording | 1 | 2022 | 955 | 0.030 |
Why?
|
Reference Standards | 1 | 2019 | 1004 | 0.030 |
Why?
|
Switzerland | 1 | 2016 | 323 | 0.030 |
Why?
|
Leukoencephalopathy, Progressive Multifocal | 1 | 2017 | 133 | 0.030 |
Why?
|
Review Literature as Topic | 1 | 2018 | 349 | 0.030 |
Why?
|
Feasibility Studies | 2 | 2018 | 5201 | 0.030 |
Why?
|
Area Under Curve | 1 | 2019 | 1636 | 0.030 |
Why?
|
Thrombectomy | 1 | 2020 | 708 | 0.030 |
Why?
|
Spin Labels | 1 | 2016 | 336 | 0.030 |
Why?
|
Analysis of Variance | 2 | 2015 | 6238 | 0.030 |
Why?
|
Models, Biological | 2 | 2018 | 9467 | 0.030 |
Why?
|
Longitudinal Studies | 3 | 2016 | 14495 | 0.030 |
Why?
|
Pyrazines | 1 | 2020 | 1199 | 0.030 |
Why?
|
Evoked Potentials | 1 | 2020 | 1036 | 0.030 |
Why?
|
Diffusion Tensor Imaging | 1 | 2024 | 2385 | 0.030 |
Why?
|
Motor Activity | 1 | 2024 | 2687 | 0.030 |
Why?
|
Observation | 1 | 2015 | 312 | 0.030 |
Why?
|
Hypothermia | 1 | 2015 | 188 | 0.030 |
Why?
|
Poverty Areas | 1 | 2014 | 264 | 0.030 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2018 | 621 | 0.030 |
Why?
|
Intubation, Intratracheal | 1 | 2020 | 1328 | 0.030 |
Why?
|
Supine Position | 1 | 2012 | 205 | 0.030 |
Why?
|
Electrooculography | 1 | 2012 | 113 | 0.030 |
Why?
|
Cross-Over Studies | 1 | 2018 | 2061 | 0.030 |
Why?
|
Pattern Recognition, Automated | 1 | 2018 | 994 | 0.030 |
Why?
|
Postoperative Period | 1 | 2017 | 1818 | 0.030 |
Why?
|
Decision Support Systems, Clinical | 1 | 2021 | 1164 | 0.020 |
Why?
|
Medical History Taking | 1 | 2016 | 773 | 0.020 |
Why?
|
Numerical Analysis, Computer-Assisted | 1 | 2012 | 119 | 0.020 |
Why?
|
Behavior | 1 | 2014 | 540 | 0.020 |
Why?
|
Thrombolytic Therapy | 1 | 2020 | 2108 | 0.020 |
Why?
|
Postmortem Changes | 1 | 2010 | 119 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2016 | 2852 | 0.020 |
Why?
|
Self Care | 1 | 2016 | 793 | 0.020 |
Why?
|
Pandemics | 2 | 2020 | 8624 | 0.020 |
Why?
|
Disability Evaluation | 1 | 2017 | 1826 | 0.020 |
Why?
|
Meta-Analysis as Topic | 1 | 2014 | 1376 | 0.020 |
Why?
|
Regression Analysis | 1 | 2018 | 6360 | 0.020 |
Why?
|
gamma-Aminobutyric Acid | 1 | 2015 | 1132 | 0.020 |
Why?
|
Internationality | 1 | 2014 | 1004 | 0.020 |
Why?
|
Missouri | 1 | 2008 | 114 | 0.020 |
Why?
|
Infusions, Intravenous | 1 | 2013 | 2234 | 0.020 |
Why?
|
Functional Laterality | 1 | 2015 | 2253 | 0.020 |
Why?
|
Neurons | 2 | 2024 | 9426 | 0.020 |
Why?
|
Hospitals, University | 1 | 2008 | 568 | 0.020 |
Why?
|
Culture Media | 1 | 2008 | 900 | 0.020 |
Why?
|
Odds Ratio | 1 | 2018 | 9716 | 0.020 |
Why?
|
Patient Compliance | 1 | 2016 | 2688 | 0.020 |
Why?
|
Blood | 1 | 2008 | 586 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2020 | 12531 | 0.020 |
Why?
|
Photic Stimulation | 1 | 2012 | 1967 | 0.020 |
Why?
|
Neoplasms | 1 | 2014 | 22072 | 0.020 |
Why?
|
Survival Analysis | 1 | 2017 | 10182 | 0.010 |
Why?
|
Medicare | 1 | 2022 | 6786 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2018 | 12427 | 0.010 |
Why?
|
Vestibular Nuclei | 1 | 2002 | 22 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2013 | 8158 | 0.010 |
Why?
|
Gravitation | 1 | 2002 | 82 | 0.010 |
Why?
|
Drug Delivery Systems | 1 | 2013 | 2221 | 0.010 |
Why?
|
Vestibular Nerve | 1 | 2002 | 101 | 0.010 |
Why?
|
Reflex, Vestibulo-Ocular | 1 | 2002 | 86 | 0.010 |
Why?
|
Emergency Service, Hospital | 1 | 2021 | 7818 | 0.010 |
Why?
|
Referral and Consultation | 1 | 2014 | 3598 | 0.010 |
Why?
|
Haplorhini | 1 | 2002 | 529 | 0.010 |
Why?
|
Neurobiology | 1 | 2002 | 137 | 0.010 |
Why?
|
Disease Progression | 1 | 2017 | 13502 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2022 | 20509 | 0.010 |
Why?
|
Rats | 1 | 2013 | 23711 | 0.010 |
Why?
|
Phenotype | 1 | 2012 | 16546 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2013 | 18137 | 0.010 |
Why?
|
Infant | 1 | 2015 | 36060 | 0.010 |
Why?
|
Animals | 2 | 2013 | 167963 | 0.000 |
Why?
|